Medicare Drug Price Negotiations: Selected Drugs for 2028
Last week, the Centers for Medicare and Medicaid Services (CMS) announced the selection of the group of 15 drugs for the third cycle of negotiations under the Medicare Drug Price Negotiation Program. This program, established by the Inflation Reduction Act (IRA), requires CMS to identify a number of drugs for […]

